Document:

Exhibit
10.1

 

EXECUTIVE
EMPLOYMENT AGREEMENT

 

This
Executive Employment Agreement (the “Agreement”) is made and entered into effective as of September 29, 2020
(the “Effective Date”), by and between Snehal Patel (the “Executive”) and Greenwich Lifesciences,
Inc., a Delaware corporation (the “Company”).

 

R
E C I T A L S

 

Whereas,
the parties wish to enter into an employment agreement between the Executive and the Company on the terms and conditions contained
in this Agreement, which Agreement will supersede all prior agreements and understandings between the parties, oral or written,
with respect to the subject matter of this Agreement.

 

AGREEMENT

 

NOW,
THEREFORE, in consideration of the mutual covenants herein contained and the employment of Executive by the Company, the parties
hereby agree as follows:

 

1.
Definition of Terms. The following capitalized terms used in this Agreement, but not otherwise defined herein, shall have
the following meanings:

 

(a)
“Cause” shall mean any of the following: (i) the commission of an act of fraud, embezzlement or material dishonesty
which is intended to result in substantial personal enrichment of Executive in connection with Executive’s employment with
the Company; (ii) Executive’s conviction of, or plea of nolo contendere, to a crime constituting a felony (other
than traffic-related offenses); (iii) Executive’s willful misconduct that is materially injurious to the Company; (iv) a
material breach of Executive’s Confidentiality Agreement (as defined in Section 14 below) that is materially injurious
to the Company; or (v) Executive’s (1) material failure to perform his duties as an officer of the Company, and (2) failure
to “cure” any such failure within thirty (30) days after receipt of written notice from the Company delineating the
specific acts that constituted such material failure and the specific actions necessary, if any, to “cure” such failure.

 

(b)
“Change of Control” shall mean the occurrence of any of the following events:

 

(i)
the date on which any “person” (as such term is used in Sections 13(d) and 14(d) of the Securities Exchange Act of
1934, as amended (the “Exchange Act”)) obtains “beneficial ownership” (as defined in Rule 13d-3
of the Exchange Act) or a pecuniary interest in fifty percent (50%) or more of the combined voting power of the Company’s
then outstanding securities (“Voting Stock”);

 

(ii)
the consummation of a merger, consolidation, reorganization, or similar transaction involving the Company, other than a transaction:
(1) in which substantially all of the holders of the Voting Stock immediately prior to such transaction hold or receive directly
or indirectly fifty percent (50%) or more of the voting stock of the resulting entity or a parent company thereof, in substantially
the same proportions as their ownership of the Company immediately prior to the transaction; or (2) in which the holders of the
Company’s capital stock immediately before such transaction will, immediately after such transaction, hold as a group on
a fully diluted basis the ability to elect at least a majority of the authorized directors of the surviving entity (or a parent
company); or

 

    - 1 -

     

    

 

(iii)
there is consummated a sale, lease, license or disposition of all or substantially all of the consolidated assets of the Company
and its subsidiaries, other than a sale, lease, license or disposition of all or substantially all of the consolidated assets
of the Company and its subsidiaries to an entity, fifty percent (50%) or more of the combined voting power of the voting securities
of which are owned by stockholders of the Company in substantially the same proportions as their ownership of the Company immediately
prior to such sale, lease, license or disposition.

 

(c)
“Disability” means a physical or mental disability, which prevents Executive from performing Executive’s
duties under this Agreement for a period of at least 120 consecutive days in any twelve month period or 150 non consecutive days
in any twelve month period.

 

(d)
“Good Reason” shall mean, without Executive’s express written consent, any of the following: (i) a significant
reduction of Executive’s duties, position or responsibilities relative to Executive’s duties, position or responsibilities
in effect immediately prior to such reduction, or the removal of Executive from such position, duties or responsibilities; (ii)
a reduction of Executive’s compensation as in effect immediately prior to such reduction; (iii) a material breach by the
Company of this Agreement or any other agreement with Executive that is not corrected within fifteen (15) days after written notice
from Executive (or such earlier date that the Company has notice of such material breach); or (iv) the failure of the Company
to obtain the written assumption of this Agreement by any successor contemplated in Section 12 below. “Good Reason”
shall not be deemed to exist, however, unless (1) Executive shall have given written notice to the Company specifying in reasonable
detail the Company’s acts or omissions that Executive alleges constitute “Good Reason” within ninety (90) days
after the first occurrence of such circumstances and the Company shall have failed to cure any such act or omission within thirty
(30) days of receipt of such written notice, and (2) Executive actually terminates employment within sixty (60) days following
the expiration of the Company’s cure period as set forth above. Otherwise, any claim of such circumstances as “Good
Reason” shall be deemed irrevocably waived by Executive.

 

2.
Duties and Scope of Position. During the Employment Term (as defined below), Executive will serve as Chief Executive Officer
of the Company, reporting to the Chairman of the Company, and assuming and discharging such responsibilities as are commensurate
with Executive’s position. During the Employment Term, Executive will provide services in a manner that will faithfully
and diligently further the business of the Company and will devote a substantial portion of Executive’s business time, attention
and energy thereto. Notwithstanding the foregoing, nothing in this Agreement shall restrict Executive from managing his investments,
other business affairs or operations and other matters or serving on civic or charitable boards or committees, provided,
however, that no such activities unduly interfere with the performance of his obligations under this Agreement, and further
provided that Executive shall honor the non-competition and non-solicitation terms as per Section 15 below. During
the Employment Term, Executive agrees to disclose to the Company those other companies of which he is a member of the Board of
Directors, an executive officer, or a consultant.

 

    - 2 -

     

    

 

3.
Term. The term of Executive’s employment under this Agreement shall commence as of the Effective Date and shall continue
until December 31, 2021, unless earlier terminated in accordance with Section 9 hereof; provided, however,
the term of Executive’s employment hereunder shall be automatically extended for successive additional one (1) year periods
unless the Executive or the Company delivers to the other party a written notice of its/his intent not to renew the Employment
Term (as defined below), such written notice to be delivered at least sixty (60) days prior to the expiration of the then-effective
Employment Term. The period commencing as of the Effective Date and ending on December 31, 2021 or such later date to which the
term of Executive’s employment under the Agreement shall have been extended pursuant to this Section 3 is referred
to herein as the “Employment Term” and the last day of the Employment Term is referred to herein as the “Expiration
Date.”

 

4.
Base Compensation; Equity Grant. The Company shall pay to Executive a base compensation (the “Base Compensation”)
of $450,000 (four hundred fifty thousand dollars) per year payable in cash in accordance with the Company’s standard payroll
policies. In addition, each year during the Employment Term, Executive shall be reviewed for purposes of determining the appropriateness
of increasing his Base Compensation hereunder. For purposes of the Agreement, the term “Base Compensation”
as of any point in time shall refer to the Base Compensation as adjusted pursuant to this Section 4. Base Compensation
will be pro-rated based on the number of days Executive was employed by the Company during any given year. In addition, Executive
will be eligible for equity grants (the “Equity Grant”) in the form of stock or options or other equivalents
as mutually agreed upon by the Executive and the Board of Directors. As of the Effective Date, the Executive will continue to
receive common stock grants per the vesting schedule as approved by the Board of Directors and listed on Attachment D, Stock Grant
For Services, in the Board resolution dated September 30, 2019. The Executive may defer Base Compensation or Equity Grant at any
time for any reason at his sole discretion.

 

5.
Target Bonus. In addition to his Base Compensation and Equity Grant, Executive shall be given the opportunity to earn an
annual bonus (the “Bonus”) of up to 50% of Base Compensation. The Bonus shall be earned by Executive upon the
Company’s achievement of performance milestones for a fiscal year (in each case, the “Target Year”) to
be mutually agreed upon by the Executive and the Board of Directors of the Company (the “Board”) or its compensation
committee (the “Compensation Committee”). Such performance milestones shall be established by December 31 of
the prior year of the Target Year. The Bonus for a Target Year shall be paid before December 20 of the Target Year, even if the
Executive is no longer employed by the Company at the time the Bonus is due. In the event Executive is employed by the Company
for less than the full Target Year for which a Bonus is earned pursuant to this Section 5, Executive shall be entitled
to receive a pro-rated Bonus for such Target Year based on the number of days Executive was employed by the Company during such
Target Year divided by 365 (the “Pro-Rated Bonus”). The determinations of the Board or the Compensation Committee
with respect to Bonuses will be final and binding. The Pro-Rated Bonus for the 2020 Target Year will be guaranteed and will be
paid before December 20, 2020. If the Phase III clinical trial for GP2 is initiated before the end of 2020, an additional Bonus
of $50,000 will be payable before the end of 2020. In 2021 and beyond the Bonus will be based on the achievement of mutually agreed
operating goals for that year. To be clear, a 100% achievement of goals will result in a bonus payment of 50% of salary. 

 

    - 3 -

     

    

 

In
addition to the above bonuses for 2020 and future Target Years, the Executive will be eligible for a Strategic Transaction Bonus.
In the event the Company consummates any Strategic Transaction involving the Company and a counter party, regardless of the size
of the transaction, the Company shall pay to the Executive a bonus payment of 5% of the Transaction Value (as defined below) paid
or received by the Company in the transaction, payable by the Company (within 5 business days) to the Executive in the form of
consideration received by the Company at the closing of the transaction. In the event any contingent consideration is agreed to
be paid in connection with the Strategic Transaction (such as, for example, consideration payable upon the fulfillment of some
condition or event which may or may not occur in the future), then such contingent consideration shall be included in the Transaction
Value, and the Executive shall be paid his bonus with respect to that contingent consideration as and when it is received by the
Company, even if contingent consideration is received after termination of employment or death of the Executive.

 

As
used herein, Strategic “Transaction Value” shall include any of the following up to closing or thereafter: (i) cash
paid in the transaction, (ii) the fair market value of any equity, equity-related, convertible, or debt securities issued, (iii)
the fair market value of any other property transferred, (iv) balance sheet indebtedness assumed in connection with the transaction,
and (v) all technology access/license fees, net royalty payments (total royalty payments paid to the Company minus total royalty
payments paid by the Company to other parties) after launch of any product, commercialization or any other milestone bonus payments
to the Company by a counter party or the converse up to closing or thereafter. If a closed Strategic Transaction is modified,
extended, expanded or replaced with another transaction or a replacement transaction at any time, including after the first Strategic
Transaction is terminated, then the Company shall make Bonus Payments based on the cumulative Transaction Value, which would include
the Transaction Value, as defined above, from all transactions.

 

Any
Bonus will be payable to the Executive if the performance milestones were achieved or Strategic Transactions were consummated
(or “Earned”) while the Executive was employed in any capacity (or if such Strategic Transaction was initiated by
the Executive while employed and was consummated within 18 months after termination of the Executive). If any Bonus was Earned
pursuant to this Agreement, including any Earned contingent or future payments related to a consummated Strategic Transaction,
it will be payable even after the termination of the Executive for any cause, and in addition, will be payable to the Executive’s
estate or heirs upon his death.

 

6.
Benefits. Executive shall participate in all employee welfare and benefit plans and shall receive such other fringe benefits
as the Company offers to its senior executives and directors.

 

    - 4 -

     

    

 

7.
Termination.

 

(a)
Termination by the Company. Subject to the obligations of the Company set forth in this Agreement, the Company may terminate
Executive’s employment at any time and for any reason (or no reason), and with or without Cause, and without prejudice to
any other right or remedy to which the Company or Executive may be entitled at law or in equity or under this Agreement or otherwise.
Notwithstanding the foregoing, in the event the Company desires to terminate the Executive’s employment without Cause, the
Company shall give the Executive not less than sixty (60) days advance written notice. Executive’s employment shall terminate
automatically in the event of his death.

 

(b)
Termination by Executive. Executive may voluntarily terminate the Employment Term upon sixty (60) days’ prior written
notice for any reason or no reason. Executive may terminate the Employment Term for Good Reason by giving written notice of resignation
for Good Reason in accordance with the definition thereof set forth in Section 1(d) above. Termination by Executive pursuant
to this Section 7(b) shall be without prejudice to any right or remedy to which the Company or Executive may be entitled
at law or in equity or under this Agreement or otherwise.

 

(c)
Termination for Death or Disability. Subject to the obligations of the Company set forth in this Agreement and without
prejudice to any other right or remedy to which the Company or Executive may be entitled at law or in equity or under this Agreement
or otherwise, Executive’s employment shall terminate automatically upon his death. Additionally, subject to the obligations
of the Company in this Agreement and without prejudice to any other right or remedy to which the Company or Executive may be entitled
at law or in equity or under this Agreement or otherwise, in the event Executive is unable to perform his duties as a result of
Disability during the Employment Term, the Company shall have the right to terminate the employment of Executive by providing
written notice of the effective date of such termination.

 

(d)
Expiration of Employment Term. Subject to the obligations of the Company set forth in this Agreement and without prejudice
to any other right or remedy to which the Company or Executive may be entitled at law or in equity under this Agreement or otherwise,
Executive’s employment hereunder shall terminate automatically upon the Expiration Date.

 

    - 5 -

     

    

 

8.
Payments Upon Termination of Employment.

 

(a)
Termination for Cause, Death or Disability, Termination by Executive without Good Reason or Expiration of the Term. In
the event that Executive’s employment hereunder is terminated during the Employment Term by the Company for Cause pursuant
to Section 7(a), as a result of Executive’s death or Disability pursuant to Section 7(c) or voluntarily by
Executive without Good Reason pursuant to Section 7(b) or upon expiration of the Employment Period, the Company shall compensate
Executive (or in the case of death, Executive’s estate) as follows: (i) on the date of termination the Company shall pay
to the Executive, a lump sum amount equal to (A) any portion of unpaid Base Compensation and Equity Grant then due for periods
on or prior to the effective date of termination plus (B) any Bonus earned and not yet paid through the date of termination; (ii)
within 2-1/2 months following submission of proper expense reports by Executive or Executive’s estate, all expenses reasonably
and necessarily incurred by Executive in connection with the business of the Company prior to the date of termination; (iii) only
in the event of Executive’s death or Disability pursuant to Section 7(c) or in the event of the expiration of the
Employment Period as a result of non-renewal by the Company in accordance with Section 3 hereof, on the date that the Bonus
for the Target Year in which the date of termination occurs would have been payable had Executive remained employed by the Company
through such payment date, payment of the Pro-Rated Bonus for the Target Year in which the date of termination occurs.

 

(b)
Termination by Company Without Cause or by Executive For Good Reason. In the event that Executive’s employment is
terminated during the Employment Term by the Company without Cause pursuant to Section 7(a) or by Executive for Good Reason
pursuant to Section 7(b), the Company shall compensate Executive as follows: (i) on the date of termination, the Company
shall pay to the Executive a lump sum amount equal to (A) any portion of unpaid Base Compensation and Equity Grant then due for
periods on or prior to the effective date of termination plus (B) any Bonus earned and not yet paid through the date of termination;
(ii) within 2-1/2 months following submission of proper expense reports by Executive, all expenses reasonably and necessarily
incurred by Executive in connection with the business of the Company prior to the date of termination; and (iii) on the date that
the Bonus for the Target Year in which the date of termination occurs would have been payable had Executive remained employed
by the Company through such payment date, payment of the Pro-Rated Bonus for the Target Year in which the date of termination
occurs; and (iv) provided that Executive executes a written release, substantially in the form attached hereto as Exhibit A,
of any and all claims against the Company and all related parties with respect to all matters arising out of Executive’s
employment by the Company (the “Release”) and the Release becomes effective (and no longer subject to revocation)
within sixty (60) days following the date of termination, the Company shall (y) pay to the Executive the Severance Payment (as
defined below), which Severance Payment shall be paid within five (5) business days following the date the Release becomes effective
(and no longer subject to revocation) and (z) reimburse Executive’s payment of COBRA premiums for twelve (12) months from
the date of termination. As used herein, “Severance Payment” means an amount equal to twelve (12) months of
Employee’s Base Compensation and Equity Grant at the rate in effect as of the date of termination (or, in the case of a
resignation for Good Reason due to a reduction in Base Salary, at the Base Salary rate in effect immediately prior to such reduction).
In the event Executive’s employment is terminated without Cause or for Good Reason and a Change of Control of the Company
occurs within six (6) months of such termination, Executive also shall be entitled to the severance benefits set forth under Section
8(c). To the extent the review or revocation period applicable to the Release spans two of Executive’s taxable years,
the Severance Payment shall not be paid until the later taxable year. If the Company’s reimbursement of Executive’s
payment of COBRA premiums pursuant to Section 10(b) or Section 10(c) would subject the Company to any tax or penalty under the
Patient Protection and Affordable Care Act or Section 105(h) of the Code (“Section 105(h)”), Executive and
the Company agree to work together in good faith to restructure such benefit.

 

    - 6 -

     

    

 

(c)
Termination in the Context of a Change of Control. Notwithstanding anything in Section 8(a) or Section
8(b) to the contrary, in the event of Executive’s termination of employment with the Company either (i) by the Company
without Cause or Executive for Good Reason at any time within six (6) months prior to the consummation of a Change of Control
if, prior to or as of such termination, a Change of Control transaction was Pending (as defined in Section 8(d) below)
at any time during such six (6)-month period, (ii) by Executive for Good Reason at any time within twelve (12) months after the
consummation of a Change of Control, or (iii) by the Company without Cause at any time within twelve (12) months after the consummation
of a Change of Control, then, Executive shall be entitled to the following payments and other benefits:

 

(i)
on the date of termination (except as specified in clauses (D)), the Company shall pay to the Executive a lump sum amount equal
to (A) any portion of unpaid Base Compensation and Equity Grant then due for periods prior to the effective date of termination;
(B) any Bonus earned and not yet paid through the date of termination, (C) within 2-1/2 months following submission of proper
expense reports by Executive, all expenses reasonably and necessarily incurred by Executive in connection with the business of
the Company prior to the date of termination, and (D) on the date that the Bonus for the Target Year in which the date of termination
occurs would have been payable had Executive remained employed by the Company through such payment date, payment of the Pro-Rated
Bonus for the Target Year in which the date of termination occurs;

 

(ii)
provided Executive executes the Release and the Release become effective (and no longer subject to revocation) within sixty (60)
days following the date of termination (or, in the event case of a termination of Executive’s employment without Cause or
for Good Reason within the six (6) months prior to the consummation of a Change in Control, Executive either (y) previously executed
the Release in accordance with Section 8(b)(ii) above or (z) subsequently executes the Release and the Release becomes
effective (and no longer subject to revocation) within sixty (60) days following the Change in Control): (A) the Company shall
pay to Executive a lump sum amount equal to twelve (12) months of Executive’s Base Compensation and Equity Grant at the
rate in effect as of the date of termination (or, in the case of a resignation for Good Reason due to a reduction in Base Salary,
at the Base Salary rate in effect immediately prior to such reduction), which payment shall be made (1) in the case of such termination
upon or following the Change of Control, within five (5) business days following the date that the Release becomes effective (and
no longer subject to revocation) or (2) in the case of such termination prior to a Change of Control, immediately upon the consummation
of the Change of Control (or, if the Release was not previously executed in accordance with Section 8(b)(ii) above, within
five (5) business days following the date that the Release becomes effective (and no longer subject to revocation)); and (B) the
Company shall reimburse Executive for the COBRA premiums he pays to maintain health insurance coverage for six (6) months following
the date of termination;

 

(iii)
notwithstanding any provision of any stock incentive plan, stock option agreement, realization bonus, restricted stock agreement
or other agreement relating to capital stock of the Company, all of the shares that are then unvested shall immediately vest and,
with respect to all options, warrants and other convertible securities of the Company beneficially held by Executive, become fully
exercisable for (A) a period of six months following the date of termination only if at the time of such termination there is
a Change of Control transaction Pending (as defined in Section 8(d) below) but in no event beyond expiration of the original
term of the award or (B) if clause (A) does not apply, then such period of time set forth in the agreement evidencing the security;
and

 

    - 7 -

     

    

 

(iv)
Severance benefits under this Section 10(c) and Section 10(b) above shall be mutually exclusive and severance under one such section
shall prohibit severance under the other.

 

(d)
Definition of “Pending.” For purposes of Section 10(c), a Change of Control transaction shall be deemed to
be “Pending” each time any of the following circumstances exist: (A) the Company and a third party have entered
into a confidentiality agreement that has been signed by a duly-authorized officer of the Company and that is related to a potential
Change of Control transaction; or (B) the Company has received a written expression of interest from a third party, including
a binding or non-binding term sheet or letter of intent, related to a potential Change of Control transaction.

 

(e)
If Executive’s employment terminates for any reason, Executive shall have no obligation to seek other employment and there
shall be no setoff against amounts due to him under this Agreement for income or benefits from any subsequent employment.

 

9.
Indemnification. The Company agrees to indemnify and hold harmless Executive, to the fullest extent permitted by the laws
of the State of Delaware and applicable federal law in effect on the date hereof, or as such laws may be amended to increase the
scope of such permitted indemnification, against any and all Losses if Executive was or is or becomes a party to or participant
in, or is threatened to be made a party to or participant in, any Claim by reason of or arising in part out of an Indemnifiable
Event, including, without limitation, Claims brought by or in the right of the Company, Claims brought by third parties, and Claims
in which Executive is solely a witness. For purposes of this section, “Claim” means any proceeding, threatened
or contemplated civil, criminal, administrative or arbitration action, suit or proceeding and any appeal therein and any inquiry
or investigation which could lead to such action, suit or proceeding. “Indemnifiable Event” means any event or occurrence,
whether occurring before, on or after the effective date of this Agreement, related to the fact that Executive was a director,
officer, employee or agent of the Company or by reason of an action or inaction by Company in any such capacity whether or not
serving in such capacity at the time any Loss is incurred for which indemnification can be provided under this Agreement. “Losses”
means any and all damages, losses, liabilities, judgments, fines, penalties (whether civil, criminal or other), ERISA excise taxes,
amounts paid or payable in settlement, including any interest, assessments, reasonable expenses, including attorney’s fees,
experts’ fees, court costs, transcript costs, travel expenses, printing, duplication and binding costs, and telephone charges,
and all other charges paid or payable in connection with investigating, defending, being a witness in or participating (including
on appeal), or preparing to defend, be a witness or participate in, any Claim. The Company further agrees to maintain a directors
and officers liability insurance policy covering Executive in an amount, and on terms no less favorable to him than the coverage
the Company provides other senior executives and directors.

 

    - 8 -

     

    

 

10.
Successors. Any successor to the Company (whether direct or indirect and whether by purchase, lease, merger, consolidation,
liquidation or otherwise) to all or substantially all of the Company’s business and/or assets or otherwise pursuant to a
Change of Control shall assume the Company’s obligations under this Agreement and agree expressly in writing to perform
the Company’s obligations under this Agreement in the same manner and to the same extent as the Company would be required
to perform such obligations in the absence of a succession. For all purposes under this Agreement, the term “Company”
shall include any successor to the Company’s business and/or assets (including any parent company to the Company), whether
or not in connection with a Change of Control, which becomes bound by the terms of this Agreement by operation of law or otherwise.

 

11.
Notices. Notices and all other communications contemplated by this Agreement shall be in writing (including email) and
shall be deemed to have been duly given when personally delivered (if to the Company, addressed to its Secretary at the Company’s
principal place of business on a non-holiday weekday between the hours of 9 a.m. and 5 p.m.; if to Executive, via personal service
to his last known residence) or three business days following the date it is mailed by U.S. registered or certified mail, return
receipt requested and postage prepaid.

 

12.
Confidential Information.Executive recognizes and acknowledges that by reason of Executive’s employment
by and service to the Company before, during and, if applicable, after the Employment Term, Executive will have access to certain
confidential and proprietary information relating to the Company’s business, which may include, but is not limited to, trade
secrets, trade “know-how,” product development techniques and plans, formulas, customer lists and addresses, financing
services, funding programs, cost and pricing information, marketing and sales techniques, strategy and programs, computer programs
and software and financial information (collectively referred to herein as “Confidential Information”). “Confidential
Information” does not include general skills and experience or information that is generally available to the public or
in the Company’s industry. Executive acknowledges that such Confidential Information is a valuable and unique asset of the
Company and Executive covenants that he will not, unless expressly authorized in writing by the Company, at any time during the
course of Executive’s employment use any Confidential Information or divulge or disclose any Confidential Information to
any person, firm or corporation except (a) in connection with the performance of Executive’s duties for and on behalf of
the Company and in a manner consistent with the Company’s policies regarding Confidential Information, (b) when required
to do so by a court of law, by any governmental agency having supervisory authority over the business of the Company or by any
administrative or legislative body (including a committee thereof) with apparent jurisdiction to order Executive to divulge, disclose
or make accessible such information or (c) such information is in the public domain through no fault of Executive. Executive also
covenants that at any time after the termination of such employment, directly or indirectly, he will not use any Confidential
Information or divulge or disclose any Confidential Information to any person, firm or corporation, unless such information is
in the public domain through no fault of Executive or except when required to do so by a court of law, by any governmental agency
having supervisory authority over the business of the Company or by any administrative or legislative body (including a committee
thereof) with apparent jurisdiction to order Executive to divulge, disclose or make accessible such information. All written Confidential
Information (including, without limitation, in any computer or other electronic format) which comes into Executive’s possession
during the course of Executive’s employment shall remain the property of the Company. Unless expressly authorized in writing
by the Company, Executive shall not remove any written Confidential Information from the Company’s premises, except in connection
with the performance of Executive’s duties for and on behalf of the Company and in a manner consistent with the Company’s
policies regarding Confidential Information. Upon termination of Executive’s employment, the Executive agrees to immediately
return to the Company all written Confidential Information (including, without limitation, in any computer or other electronic
format) in Executive’s possession.

 

    - 9 -

     

    

 

13.
Non-Competition; Non-Solicitation.

 

(a)
Non-Compete. The Executive hereby covenants and agrees that during the Employment Term and for a period of one year following
the Expiration Date, the Executive will not, without the prior written consent of the Company, directly or indirectly, on his
own behalf or in the service or on behalf of others, whether or not for compensation, engage in any business activity, or have
any interest in any person, firm, corporation or business, through a subsidiary or parent entity or other entity (whether as a
shareholder, agent, joint venturer, security holder, trustee, partner, executive, creditor lending credit or money for the purpose
of establishing or operating any such business, partner or otherwise) with any entity that is directly competing with the products
being developed by the Company, which in the case of GP2 would be any entity pursuing HER2/neu 3+ breast cancer products in the
adjuvant/neoadjuvant setting that would be seeking to prevent the recurrence of breast cancer.

 

(b)
Non-Solicitation. The Executive further agrees that during the Employment Term and for a period of one (1) year from the
Expiration Date, the Executive will not divert any business of the Company and/or its affiliates or any customers or suppliers
of the Company and/or the Company’s and/or its affiliates’ business to any other person, entity or competitor, or
induce or attempt to induce, directly or indirectly, any person to leave his or her employment with the Company and/or its affiliates;
provided, however, that the foregoing provisions shall not apply to a general advertisement or solicitation program
that is not specifically targeted at such employees.

 

(c)
Remedies. The Executive acknowledges and agrees that his obligations provided herein are necessary and reasonable in order
to protect the Company and its affiliates and their respective business and the Executive expressly agrees that monetary damages
would be inadequate to compensate the Company and/or its affiliates for any breach by the Executive of his covenants and agreements
set forth herein. Accordingly, the Executive agrees and acknowledges that any such violation or threatened violation of this Section
13 will cause irreparable injury to the Company and that, in addition to any other remedies that may be available, in law,
in equity or otherwise, the Company and its affiliates shall be entitled to obtain injunctive relief against the threatened breach
of this Section 13 or the continuation of any such breach by the Executive without the necessity of proving actual damages.

 

    - 10 -

     

    

 

14.
Employment Relationship. Executive’s employment with the Company will be “at will,” meaning that, subject
to the Company’s obligations set forth in Section 8, either Executive or the Company may terminate Executive’s
employment at any time and for any reason, with or without Cause or Good Reason. Any contrary representations that may have been
made to Executive are superseded by this Agreement. This is the full and complete agreement between Executive and the Company
on this term. Although Executive’s duties, title, compensation and benefits, as well as the Company’s personnel policies
and procedures, may change from time to time, the “at will” nature of Executive’s employment may only be changed
in an express written agreement signed by Executive and a duly authorized officer of the Company (other than Executive).

 

15.
Section 409A. It is intended that each installment of the payments provided hereunder constitute separate “payments”
for purposes of Treasury Regulation Section 1.409A-2(b)(2)(i). It is further intended that payments hereunder satisfy, to the
greatest extent possible, the exemption from the application of Section 409A provided under Treasury Regulation Section 1.409A-1(b)(4)
(as a “short-term deferral”). To the extent that any provision of this Agreement is ambiguous as to its compliance
with Section 409A, the provision will be read in such a manner so that all payments hereunder comply with Section 409A. Except
as otherwise expressly provided herein, to the extent any expense reimbursement or the provision of any in-kind benefit under
this Agreement is determined to be subject to Section 409A, the amount of any such expenses eligible for reimbursement, or the
provision of any in-kind benefit, in one calendar year shall not affect the expenses eligible for reimbursement in any other taxable
year (except for any lifetime or other aggregate limitation applicable to medical expenses), in no event shall any expenses be
reimbursed after the last day of the calendar year following the calendar year in which Executive incurred such expenses, and
in no event shall any right to reimbursement or the provision of any in-kind benefit be subject to liquidation or exchange for
another benefit. In no event whatsoever will the Company be liable for any additional tax, interest or penalties that may be imposed
on Executive under Section 409A or any damages for failing to comply with Section 409A.

 

16.
280G Excise Tax. Notwithstanding any other provisions in this Agreement, in the event that any payment or benefit received
or to be received by Executive under this Agreement or under any other agreement between Executive and the Company or otherwise
(collectively, the “Total Payments”) would be subject (in whole or part), to any excise tax imposed under Section
4999 of the Internal Revenue Code of 1986, as amended (the “Code”), or any successor provision thereto (the
“Excise Tax”), then the Company will reduce the Total Payments to the extent necessary so that no portion of
the Total Payments is subject to the Excise Tax (but in no event to less than zero); provided, however,
that the Total Payments will only be reduced to the extent that the after-tax value of amount received by Executive after
application of the above reduction would exceed the after-tax value of amount received by Executive without application of such
reduction. For this purpose, the after-tax value of an amount shall be determined taking into account all federal, state, municipal
and local income, taxes, employment taxes and any Excise Tax applicable to such amount and taking into account, if applicable,
the phase out of itemized deductions and personal exemptions attributable to such amount. In the case of a reduction in the Total
Payments, the Total Payments will be reduced in the following order (unless reduction in another order is required to avoid adverse
consequences under Section 409A of the Code, in which case, reduction will be in such other order): (i) payments that are payable
in cash that are valued at full value under Treasury Regulation Section 1.280G-1, Q&A 24(a) will be reduced (if necessary,
to zero), with amounts that are payable last reduced first; (ii) payments and benefits due in respect of any equity valued at
full value under Treasury Regulation Section 1.280G-1, Q&A 24(a), with the highest values reduced first (as such values are
determined under Treasury Regulation Section 1.280G-1, Q&A 24) will next be reduced; (iii) payments that are payable in cash
that are valued at less than full value under Treasury Regulation Section 1.280G-1, Q&A 24, with amounts that are payable
last reduced first, will next be reduced; (iv) payments and benefits due in respect of any equity valued at less than full value
under Treasury Regulation Section 1.280G-1, Q&A 24, with the highest values reduced first (as such values are determined under
Treasury Regulation Section 1.280G-1, Q&A 24) will next be reduced; and (v) all other non-cash benefits not otherwise described
in clauses (ii) or (iv) will be next reduced pro-rata. Any reductions made pursuant to each of clauses (i)-(v) above will be made
in the following manner: first, a pro-rata reduction of cash payments and payments and benefits due in respect of any equity not
subject to Section 409A of the Code, and second, a pro-rata reduction of cash payments and payments and benefits due in respect
of any equity subject to Section 409A of the Code as deferred compensation.

 

    - 11 -

     

    

 

17.
Miscellaneous Provisions.

 

(a)
Modifications; No Waiver. No provision of this Agreement may be modified, waived or discharged unless the modification,
waiver or discharge is agreed to in writing and signed by Executive and by an authorized officer of the Company (other than Executive).
No waiver by either party of any breach of, or of compliance with, any condition or provision of this Agreement by the other party
shall be considered a waiver of any other condition or provision or of the same condition or provision at another time.

 

(b)
Entire Agreement. This Agreement supersedes all prior agreements and understandings between the parties, oral or written
with respect to the subject matter of this Agreement. No modification, termination or attempted waiver shall be valid unless in
writing, signed by the party against whom such modification, termination or waiver is sought to be enforced.

 

(c)
Choice of Law. The parties agree that the laws of the State of Delaware shall govern this Agreement. The federal and state
courts situated in Delaware U.S.A. shall have jurisdiction and venue for any and all disputes arising out of or relating to this
Agreement. If either party incurs attorney, court, mediation, arbitration, or any other litigation fees or litigation/travel expenses
to enforce any rights arising out of or relating to this Agreement, the prevailing party shall be entitled to recover all of such
reasonable fees and expenses from the non-prevailing party.

 

(d)
Severability. The invalidity or unenforceability of any provision or provisions of this Agreement shall not affect the
validity or enforceability of any other provision hereof, which shall remain in full force and effect.

 

(e)
Counterparts. This Agreement may be executed in separate counterparts, any one of which need not contain signatures of
more than one party, and may be delivered by facsimile or other electronic means, but all of which shall be deemed originals and
taken together will constitute one and the same Agreement.

 

    - 12 -

     

    

 

(f)
Headings. The headings of the Articles and Sections hereof are inserted for convenience only and shall not be deemed to
constitute a part hereof nor to affect the meaning thereof.

 

(g)
Construction of Agreement. In the event of a conflict between the text of the Agreement and any summary, description or
other information regarding the Agreement, the text of the Agreement shall control.

 

(h)
Survival. Sections 10 through 17 (inclusive) of this Agreement shall survive the termination of Executive’s
employment with the Company.

 

[SIGNATURE
PAGE FOLLOWS]

 

    - 13 -

     

    

 

IN
WITNESS WHEREOF, each of the parties has executed this Agreement, in the case of the Company by its duly authorized officer, as
of the day and year first above written.

   

	COMPANY:	GREENWICH LIFESCIENCES,
    INC.

 

	 	By:
    	/s/
    David McWilliams
	 	Name: 
    	David
    McWilliams
	 	Title:
    	Chairman
    of the Board

 

	EXECUTIVE:	/s/
    Snehal Patel 
	 	SNEHAL
    PATEL

   

     

     

    

 

EXHIBIT
A

 

RELEASEEX-10.1

 Exhibit 10.1 

EMPLOYMENT AGREEMENT 

This EMPLOYMENT AGREEMENT (this “Agreement”) is entered into as of October 1, 2020 (the “Effective
Date”) by and between Charles L. Treadway (“Employee”) and CommScope, Inc., a Delaware corporation (the “Company”). 

WITNESSETH: 
 WHEREAS, the
Company desires to employ Employee in the capacity hereinafter stated, and Employee desires to be in the employ of the Company in such capacity for the period and on the terms and conditions set forth in this Agreement; 

NOW THEREFORE, in consideration of the foregoing, and the mutual agreements and covenants contained herein, the receipt and sufficiency of
which are hereby acknowledged, the parties agree as follows: 
 1. Employment. Subject to the provisions of Section 6, the
Company hereby employs Employee and Employee accepts such employment upon the terms and conditions hereinafter set forth (the “Employment”). 

2. Term of Employment. This Agreement shall be effective as of the Effective Date and shall terminate on the third anniversary
thereof, unless earlier terminated as provided in Section 6 (the “Initial Term”). Upon the expiration of the Initial Term or any Renewal Term (as defined below), Employee’s Employment shall be automatically renewed for an
additional one-year period (each such one-year period being a “Renewal Term”), unless the Company or Employee has given written notice to the other of
its intent not to renew this Agreement (a “Non-Renewal Notice”) at least 60 days prior to the expiration of the Initial Term or any Renewal Term, as the case may be. During any Renewal Term,
the terms, conditions and provisions set forth in this Agreement shall remain in effect unless modified in accordance with this Agreement. 

3. Duties; Extent of Service. 

(a) During the Employment, Employee shall serve as an employee of the Company with the title and position of President and Chief Executive
Officer. In this capacity, Employee shall have all the authority and responsibility customarily associated with such position in a company of the size and nature of the Company. Employee shall report directly to the Board of Directors of the Company
(the “Board”) or the Board of CommScope Holding Company, Inc. (“Parent”), as the context requires. In addition, Employee may be asked from time to time to serve as a director or officer of one or more of the
Company’s or Parent’s current or future direct and indirect subsidiaries, and Executive shall serve in such capacities without further compensation. Employee agrees to comply with all applicable laws and the Company’s policies and
procedures as may be adopted and changed from time to time and that are provided to Employee, including those described in the Company’s employee handbook, provided that if this Agreement conflicts with such policies or procedures, this
Agreement will control. Employee hereby accepts such employment, agrees to serve the Company in the capacity indicated, and agrees to use Employee’s best efforts in, and devote Employee’s full working time, attention, skill and energies
to, the advancement of the interests of the Company, Parent and their direct and indirect subsidiaries (collectively, the “Company Group”) and the performance of Employee’s duties and responsibilities hereunder. 

 (b) The foregoing, however, shall not be construed as preventing employee from engaging in
religious, charitable or other community or non-profit activities, or, with the prior approval of Parent’s Board, from serving on the board of directors of other companies, provided such service does not
impair Employee’s ability to fulfill Employee’s duties and responsibilities under this Agreement. 
 (c) During the Employment,
Employee shall be expected to perform his duties in both Hickory, North Carolina, and the Dallas, Texas metropolitan area, subject to required travel. 

4. Compensation. 
 (a)
During the Employment, the Company shall pay Employee a salary at the annual rate of $1,100,000 (the “Base Salary”). Such Base Salary may be increased at any time by the Board of Directors of Parent or a committee thereof. The Base
Salary shall be subject to withholding under applicable law, shall be prorated for partial years and shall be payable in semi-monthly or biweekly installments in accordance with the Company’s usual practice as in effect from time to time. The
Base Salary shall be reviewed by the Parent Board or a committee thereof on an annual basis and may be increased at any time by the Parent Board or a committee thereof in its sole and absolute discretion. 

(b) During the Employment, Employee shall be eligible to earn an annual bonus (the “Annual Bonus”) pursuant to the CommScope
Holding Company, Inc. Annual Incentive Plan (as such plan may be amended and modified, the “AIP”), targeted to be an amount equal to 150% of Base Salary at target performance (the “Target Bonus”), with opportunities
above and below such amount based on a range of performance goals established by the Parent Board or a committee thereof. The Annual Bonus, if any, shall be paid by the Company on or before the date that is thirty (30) days after the date of
the receipt by the Company of completed financial statements for such fiscal year, but in no event shall the payment of the Annual Bonus for a given fiscal year be made prior to January 1 of the immediately succeeding fiscal year or later than
March 15 of the immediately succeeding fiscal year. Employee shall be eligible to receive a prorated Annual Bonus with respect to fiscal year 2020. 

(c) Following the Effective Date, Parent will issue Employee 500,000 restricted stock units that vest in equal installments on the first three
anniversaries of the grant date, subject to Employee’s continued employment with the Company. In addition, following the Effective Date, Parent will issue to Employee an equity award pursuant to which up to 1,100,000 shares of Parent common
stock (“Shares”) may be earned, based upon the achievement of certain hurdles relating to Parent’s stock price and Employee’s continued employment with the Company over a four-year period. Such equity awards will be issued
pursuant to the Parent’s Long-Term Incentive Plan and will be memorialized in separate award certificates. 
 5. Benefits. 

(a) During the Employment, Employee shall be entitled to participate in any and all benefit plans of general application to the executives of
the Company, as may be in effect from time to time in the discretion of the Board (the “Benefit Plans”), including, by way of example only, medical, dental and life insurance plans and disability income plans, retirement
arrangements and other employee benefits plans the Board deems appropriate; provided that Employee shall not be entitled to participate in any severance program or policy of the Company other than as specifically set forth herein. Such participation
shall be subject to (i) the terms of the applicable Benefit Plan documents (including, as applicable, provisions granting discretion to the Board or any administrative or other committee provided for therein or contemplated thereby) and
(ii) generally applicable policies of the Company. 

  
 2 

 (b) During the Employment, Employee shall be entitled to paid vacation annually in
accordance with the Company’s vacation policy, as in effect from time to time; provided that, such vacation entitlement shall not be less than four (4) weeks. 

(c) The Company shall promptly reimburse Employee for all reasonable, documented business expenses incurred by Employee in connection with the
business of the Company, in accordance with the Company’s practices, as in effect from time to time, subject to Section 17(d) (“Expenses”). 

(d) Compliance with the provisions of this Section 5 shall in no way create or be deemed to create any obligation, express or implied, on
the part of the Company Group with respect to the continuation of any particular benefit or other plan or arrangement maintained by them or their subsidiaries as of or prior to the date hereof or the creation and maintenance of any particular
benefit or other plan or arrangement at any time after the date hereof. 
 6. Termination and Termination Benefits. Notwithstanding
the provisions of Section 2, the Employment shall terminate under the circumstances set forth in this Section 6. 
 (a)
Termination by the Company for Cause. The Employment may be terminated by the Company for Cause (as defined below) without further liability on the part of the Company Group, effective immediately upon written notice to Employee specifying in
reasonable detail the grounds for termination for Cause (subject to any cure periods expressly provided for in this Section 6(a)). Only the following, as determined by the Board or the Parent Board, shall constitute “Cause” for
such termination: 
 (i) Employee’s indictment, conviction of or plea of guilty or nolo contendere to, or a judgment
against Employee in any quasi-criminal judicial or administrative proceeding (including without limitation, any proceeding by a federal, state or local regulatory agency or body) with respect to, any crime constituting a felony, or a crime which
involves Employee’s moral turpitude, fraud, theft or embezzlement. For this purpose, a judgment shall include any consent decree, settlement, cease and desist order or similar conclusion to any quasi-criminal judicial or administrative
proceeding; 
 (ii) Employee’s commission of any other act of theft, dishonesty, fraud, or falsification of an
employment record in connection with the performance of his duties as an employee or director of the Company Group; 
 (iii)
Employee’s refusal to perform his duties to the Company Group or to obey the lawful and reasonable directives of the Board and Parent’s Board (so long as such lawful and reasonable directives are also consistent with Employee’s
duties, title and reporting order provided elsewhere this Agreement); 
 (iv) Employee’s gross negligence, willful
misconduct or willful malfeasance in connection with Employee’s services to the Company Group; 
 (v) Employee’s
material violation of reasonable business standards, legal requirements or any written policy of the Company or Parent applicable to Employee that relate to equal employment opportunity, discrimination, harassment or retaliation or that customarily
are punishable by termination of employment; or 

  
 3 

 (vi) Employee’s material breach of this Agreement or any
confidentiality or non-disclosure obligations under any other written agreement between Employee and any member of the Company Group. 

Notwithstanding the foregoing, in the case of any conduct described in clauses (iii), (v) or (vi) of the immediately preceding sentence, if such conduct
is reasonably susceptible of being cured, then Employee’s termination shall be for “Cause” only if Employee fails to cure such conduct to the Board’s reasonable satisfaction within ten (10) days after receiving written
notice from Company describing such conduct in reasonable detail; provided that the conduct in clause (iii) may only be cured by Employee on two separate occasions, and no cure shall be applicable to such conduct thereafter. 

(b) Termination by the Company Without Cause. The Employment may be terminated without Cause by the Company upon written notice to
Employee, and upon any such termination and subject to Section 17, Employee shall be entitled to the payment of Termination Benefits (as defined below). It is expressly agreed and understood that if this Agreement is terminated by the Company
without Cause as provided in this Section 6(b), it shall not impair or otherwise affect Employee’s Continuing Obligations (as defined below). Termination of Employment upon expiration of the Initial Term or any Renewal Term following a
decision by the Company not to extend the Term of Employment pursuant to Section 2 shall constitute a termination without Cause. 
 (c)
Termination by Employee for Good Reason. The Employment may be terminated by Employee for Good Reason (as defined below), and upon any such termination and subject to Section 17, Employee shall be entitled to the payment of Termination
Benefits, provided that Employee first delivers to the Company prior written notice, no later than sixty (60) days after the initial occurrence of any such event, of such intended termination, and provided further that the
Company fails to cure any such events indicated in such notice (to the extent such cure is reasonably possible) within thirty (30) days from the date of such notice. If such event has not been cured within such
30-day period, the termination of Employment by Employee for Good Reason shall be effective as of a date chosen by Employee within the sixty (60) day period immediately following the expiration of the 30-day cure period. Only the following, without Employee’s consent, shall constitute “Good Reason: 

(i) a material reduction in the Base Salary or Target Bonus (which, for the avoidance of doubt, shall mean a 5% or greater
reduction in the Base Salary or Target Bonus); provided that a reduction in Base Salary and/or Target Bonus that is made in connection with general reduction in the base salary and/or target bonus of all senior executives of the
Company shall not be considered a reduction in Base Salary or Target Bonus giving rise to Good Reason; 
 (ii) any material
diminution in Employee’s title, authority, duties or responsibilities as Chief Executive Officer; provided that, the appointment of another person to the role of President shall not be considered a diminution of title, authority,
duties or responsibilities giving rise to Good Reason; 
 (iii) any change in the reporting structure of Employee’s
position such that Employee is required to report, directly or indirectly, to a person other than the Board or Parent’s Board; or 

(iv) any material breach by the Company of this Agreement, including but not limited to a failure to require any successor of
the Company to assume the obligations of the Company under this Agreement pursuant to Section 15. 

  
 4 

 (d) Termination by Employee other than for Good Reason. Employee’s employment
under this Agreement may be terminated by Employee other than for Good Reason by written notice to the Board at least sixty (60) days prior to such termination. During the notice period, Employee shall diligently perform any assigned duties.
The Company may make such resignation effective at any point during the notice period. Termination of Employment upon expiration of the Initial Term or any Renewal Term following a decision by Employee not to extend the Term of Employment pursuant
to Section 2 shall constitute a termination other than for Good Reason. 
 (e) Certain Termination Benefits. Unless otherwise
specifically provided in this Agreement or otherwise required by law, all compensation and benefits payable to Employee under this Agreement shall terminate on the date of termination of the Employment; provided, however,
(a) Employee shall be entitled to receive any earned but unpaid Base Salary through the date of termination, (b) Employee shall be entitled to receive any Expenses incurred and unpaid through the date of termination and
(c) Employee’s rights under the Benefit Plans shall be determined under the provisions of such Benefit Plans (the amounts and rights described in clauses (a) through (c), collectively, the “Accrued Obligations”).
Notwithstanding the foregoing, in the event of a termination of the Employment without Cause pursuant to Section 6(b) or in the event of a termination of the Employment with the Company for Good Reason pursuant to Section 6(c), then,
subject to Section 17, the Company shall provide to Employee the following termination benefits (“Termination Benefits”) in addition to the Accrued Obligations: 

(i) an amount equal to two (2) times the sum of (A) Employee’s Base Salary and (B) Employee’s Target
Bonus, payable (X) in twenty-four (24) equal installments during a twenty-four (24) month period following the date of termination (the “Termination Benefits Period”) or (Y) if such termination occurs within
twenty-four (24) months following a “Change in Control” (as defined below), in a single lump sum cash payment following the date of termination, which payment shall be subject to withholding under applicable law and shall be made in
accordance with the Company’s usual payroll practice as in effect from time to time; 
 (ii) payment of any accrued and
unpaid bonus under the AIP with respect to the fiscal year ending immediately prior to the date that such termination occurs (payment shall be subject to withholding under applicable law and shall be made at the time when the Company pays bonuses to
its other executive officers with respect to the applicable fiscal year); 
 (iii) payment of any pro-rated bonus under the AIP with respect to the fiscal year in which such termination occurs (payment shall be subject to withholding under applicable law, shall be made at the time when the Company pays bonuses
to its other executive officers with respect to the applicable fiscal year, and shall be based on actual performance for the applicable fiscal year); and 

(iv) during the Termination Benefits Period, in periodic installments, in accordance with the Company’s usual payroll
practice as in effect from time to time, a cash payment equal to the cost the Company would have incurred had Employee continued group medical, dental, vision and/or prescription drug benefit coverage for himself and his eligible dependents under
the group health plan(s) sponsored by Company covering Employee and his eligible dependents at the time of Employee’s termination of employment (the “Health Coverage”) for the Termination Benefits Period; provided, however,
that (A) the cost of such Health Coverage shall be determined at the same level of benefits as is generally available to similarly situated employees and is subject to any modifications made to the same coverage provided to similarly situated
employees, including but not limited to termination of the group health plans sponsored by Company; (B) the Company shall pay the excess of the COBRA cost 

  
 5 

 
of such coverage over the amount that Employee would have had to pay for such coverage if he had remained employed during the Termination Benefits Period and paid the active employee rate for
such coverage (the “COBRA Cost”); and (C) the time during which Employee receives the payments pursuant to this Section 6(e)(iv) shall run concurrently with any period for which Employee is eligible to elect health
coverage under COBRA. 
 The Termination Benefits set forth in (i), (iii) and (iv) above shall continue so long as Employee remains in compliance with
Employee’s Continuing Obligations under this Agreement. The Company’s liability for Termination Benefits set forth in (i), (iii) and (iv) above shall be reduced by the amount of any severance, if any, actually paid to Employee
pursuant to any severance pay plan of the Company. Notwithstanding the foregoing, nothing in this Section 6(e) shall be construed to affect Employee’s right to receive COBRA continuation entirely at Employee’s own cost to the extent
that Employee may continue to be entitled to COBRA continuation after Employee’s right to receive payments under Section 6(e)(iv) ceases. 
 The
Company and Employee agree that the Termination Benefits paid by the Company to Employee under this Section 6(e) shall be in full satisfaction, compromise and release of any claims arising out of any termination of Employee’s employment
without Cause pursuant to Section 6(b), or a termination of Employee’s employment with the Company for Good Reason pursuant to Section 6(c). The payment of the Termination Benefits shall be contingent upon Employee’s timely
delivery as provided below of a separation agreement containing a general release of any and all claims (other than those arising or otherwise provided for under this Agreement) in a customary form reasonably satisfactory to the Company (and without
any additional obligations upon Employee beyond those provided for in, or otherwise inconsistent with, this Agreement) (the “Release”), it being understood that no Termination Benefits shall be provided unless and until Employee
timely executes and delivers, and does not rescind, the Release, except that the Release shall not require a waiver of any of the Accrued Obligations. The Release must be executed, and all revocation periods must have expired, within sixty
(60) days after the date of termination of Employment, failing which such payment or benefit shall be forfeited. The Company may elect to commence payment of Termination Benefits at any time during such sixty
(60)-day period; provided, however, that if such sixty (60)-day period begins in one taxable year and ends in the following taxable year, then the Company shall commence
payment of Termination Benefits in the second taxable year. If such payment or benefit is exempt from Section 409A of the Code, the Company may elect to make or commence payment of Termination Benefits at any time during such sixty (60)-day period. 
 For purposes of this Agreement, “Change in Control” shall mean any of the following:

 (i) an acquisition (other than directly from Parent) of any securities issued by Parent which generally entitle the holder
thereof to vote for the election of directors of Parent (“Voting Securities”) by any “person,” within the meaning of Sections 13(d) and 14(d) of the Securities Exchange Act of 1934, as amended (“Person”),
immediately after which such Person has “beneficial ownership,” within the meaning under Rule 13d-3 promulgated under the Securities Exchange Act of 1934, as amended (“Beneficial
Ownership”) of more than thirty-three percent (33%) of (i) the then-outstanding Shares or (ii) the combined voting power of Parent’s then-outstanding Voting Securities; provided, however, that in determining whether a
Change in Control has occurred pursuant to this paragraph (i), the acquisition of Shares or Voting Securities in a Non-Control Acquisition (as hereinafter defined) shall not constitute a Change in Control. A
“Non-Control Acquisition” shall mean an acquisition by (i) an employee benefit plan (or a trust forming a part thereof) maintained by (A) Parent or (B) any corporation or other
Person the majority of the voting power, voting equity securities or equity interest of which is owned, directly or indirectly, by Parent (for purposes of this definition, a “Related Entity”), (ii) Parent or any Related Entity, or
(iii) any Person in connection with a Non-Control Transaction (as hereinafter defined); 

  
 6 

 (ii) the individuals who, as of the Effective Date, are members of the Board
of Directors of Parent (the “Incumbent Board”), cease for any reason to constitute at least two-thirds of the members of the Board of Directors of Parent or, following a Merger (as hereinafter
defined), the board of directors of (i) the corporation resulting from such Merger (the “Surviving Corporation”), if fifty percent (50%) or more of the combined voting power of the then-outstanding voting securities of the
Surviving Corporation is not Beneficially Owned, directly or indirectly, by another Person (a “Holding Corporation”) or (ii) if there is one or more than one Holding Corporation, the ultimate Holding Corporation; provided,
however, that, if the election, or nomination for election by Parent’s common shareholders, of any new director was approved by a vote of at least two-thirds of the Incumbent Board, such new director
shall, for purposes of this Agreement, be considered a member of the Incumbent Board; and provided, further, however, that no individual shall be considered a member of the Incumbent Board if such individual initially assumed office as a
result of an actual or threatened solicitation of proxies or consents by or on behalf of a Person other than the Board of Directors of Parent (a “Proxy Contest”), including by reason of any agreement intended to avoid or settle any
Proxy Contest; or 
 (iii) the consummation of: 

(1) a merger, consolidation or reorganization (x) with or into Parent or (y) in which securities of Parent are issued
(a “Merger”), unless such Merger is a “Non-Control Transaction.” A “Non-Control Transaction” shall mean a Merger in which:

 (A) the shareholders of Parent immediately before such Merger own directly or indirectly immediately following such
Merger at least a majority of the combined voting power of the outstanding voting securities of (1) the Surviving Corporation, if there is no Holding Corporation or (2) if there is one or more than one Holding Corporation, the ultimate
Holding Corporation; 
 (B) the individuals who were members of the Incumbent Board immediately prior to the execution of
the agreement providing for such Merger constitute at least a majority of the members of the board of directors of (1) the Surviving Corporation, if there is no Holding Corporation, or (2) if there is one or more than one Holding
Corporation, the ultimate Holding Corporation; and 
 (C) no Person other than (1) Parent or another corporation that
is a party to the agreement of Merger, (2) any Related Entity, or (3) any employee benefit plan (or any trust forming a part thereof) that, immediately prior to the Merger, was maintained by Parent or any Related Entity, or (4) any
Person who, immediately prior to the Merger had Beneficial Ownership of thirty-three percent (33%) or more of the then outstanding Shares or Voting Securities, has Beneficial Ownership, directly or indirectly, of thirty-three percent
(33%) or more of the combined voting power of the outstanding voting securities or common stock of (x) the Surviving Corporation, if there is no Holding Corporation, or (y) if there is one or more than one Holding Corporation, the ultimate
Holding Corporation; 
 (2) a complete liquidation or dissolution of Parent; or 

  
 7 

 (3) the sale or other disposition of all or substantially all of the assets
of Parent and its subsidiaries (as defined in Section 424(f) (or a successor provision to such section) of the Code, and regulations and rulings thereunder, with Parent being treated as the employer corporation for purposes of such definition)
taken as a whole to any Person (other than (x) a transfer to a Related Entity or (y) the distribution to Parent’s shareholders of the stock of a Related Entity or any other assets). 

Notwithstanding the foregoing, a Change in Control shall not be deemed to occur solely because any Person (the “Subject Person”) acquired
Beneficial Ownership of more than the permitted amount of the then outstanding Shares or Voting Securities as a result of the acquisition of Shares or Voting Securities by Parent which, by reducing the number of Shares or Voting Securities then
outstanding, increases the proportional number of Shares Beneficially Owned by the Subject Persons; provided that if a Change in Control would occur (but for the operation of this sentence) as a result of the acquisition of Shares or Voting
Securities by Parent and, after such share acquisition by Parent, the Subject Person becomes the Beneficial Owner of any additional Shares or Voting Securities and such Beneficial Ownership increases the percentage of the then outstanding Shares or
Voting Securities Beneficially Owned by the Subject Person, then a Change in Control shall occur. 
 (f) Disability. If Employee shall
be disabled so as to be unable to perform the essential functions of Employee’s then-existing position or positions under this Agreement with or without reasonable accommodation (“Disability”), the Board may terminate the
Employment. In the event of such termination on account of Employee’s Disability, the Company Group shall have no further obligations to Employee except the Company shall provide to Employee the Accrued Obligations. If any question shall arise
as to whether during any period Employee is disabled so as to be unable to perform the essential functions of Employee’s then-existing position or positions with or without reasonable accommodation, Employee may, and at the request of the
Company shall, submit to the Company a certification in reasonable detail by a physician mutually acceptable to the Company and Employee or Employee’s guardian as to whether Employee is so disabled or how long such disability is expected to
continue, and such certification shall for the purposes of this Agreement be conclusive of the issue. Employee shall cooperate with any reasonable request of the physician in connection with such certification. If such question shall arise and
Employee shall fail to submit such certification, the Company’s determination of such issue shall be binding on Employee. Nothing in this Section 6(f) shall be construed to waive Employee’s rights, if any, under existing law
including, without limitation, the Family and Medical Leave Act of 1993, 29 U.S.C. §2601 et seq. and the Americans with Disabilities Act, 42 U.S.C. §12101 et seq. 

(g) Death. Employee’s Employment and all obligations of the Company and Employee hereunder shall terminate in the event of the
death of Employee, other than any Accrued Obligations. 
 (h) Continuing Obligations. Notwithstanding termination of this Agreement as
provided in this Section 6 (other than Section 6(g)) or any other termination of Employee’s Employment with the Company, Employee’s obligations under Sections 7 and 8 hereof (the “Continuing Obligations”) shall
survive any termination of Employee’s Employment with the Company at any time and for any reason. 
 7. Restrictive Covenants. In
consideration of Employee’s employment hereunder, Employee agrees to the following restrictions. 

  
 8 

 (a) Acknowledgments. 

(i) Access to Confidential Information and Relationships. Employee acknowledges and agrees that as a result of
Employee’s employment with the Company, Employee’s knowledge of and access to confidential and proprietary information, and Employee’s relationships with the Company Group’s customers and employees, Employee would have an unfair
competitive advantage if Employee were to engage in activities in violation of the Restrictive Covenants. Employee also acknowledges and agrees that these Restrictive Covenants are necessary to protect the trade secrets of Company. 

(ii) No Undue Hardship. Employee acknowledges and agrees that, in the event that his employment with the Company
terminates, Employee possesses marketable skills and abilities that will enable Employee to find suitable employment without violating the Restrictive Covenants. 

(iii) Voluntary Execution. Employee acknowledges and affirms that he is entering into the Agreement voluntarily and that
he has read the Agreement carefully and had a full and reasonable opportunity to consider the Restrictive Covenants (including an opportunity to consult with legal counsel). 

(b) Definitions. The following capitalized terms used in this Section 7 shall have the meanings assigned to them below, which
definitions shall apply to both the singular and the plural forms of such terms: 
 (i) “Competitive
Services” means the business of designing, building, managing, selling or representing (i) wired and wireless networks, (ii) radio frequency wireless networks including macro, metro, DAS and small cell solutions, (iii) indoor
network solutions for commercial buildings, data centers, central offices and cable television head ends, (iv) outdoor network solutions for telecom service providers and cable TV networks, including FTTX solutions, (v) appliances at homes
that deliver internet or paid TV, (vi) software and appliances in cable and telecom networks to create and manage signals for internet and video, and (vii) appliances in enterprises that deliver wired and wireless connectivity to end
users, as well as the business of providing any other activities, products, or services of the type conducted, authorized, offered, or provided by the Company Group as of Employee’s Termination Date, or during the one (1) year immediately
prior to Employee’s Termination Date. 
 (ii) “Confidential Information” means any and all data and
information relating to the Company Group, their activities, business, or clients that (i) is disclosed to Employee or of which Employee becomes aware as a consequence of his employment with the Company; (ii) has value to the Company
Group; and (iii) is not generally known outside of the Company Group. “Confidential Information” shall include, but is not limited to the following types of information regarding, related to, or concerning the Company Group: trade
secrets (as defined by N.C. Gen. Stat. § 66-152(3)); financial plans and data; management planning information; business plans; operational methods; market studies; marketing plans or strategies; pricing
information; product development techniques or plans; customer lists; customer files, data and financial information; details of customer contracts; current and anticipated customer requirements; identifying and other information pertaining to
business referral sources; past, current and planned research and development; computer aided systems, software, strategies and programs; business acquisition plans; management organization and related information (including, without limitation,
data and other information concerning the compensation and benefits paid to officers, directors, employees and management); personnel and compensation 

  
 9 

 
policies; new personnel acquisition plans; and other similar information. “Confidential Information” also includes combinations of information or materials which individually may be
generally known outside of the Company Group, but for which the nature, method, or procedure for combining such information or materials is not generally known outside of the Company Group. In addition to data and information relating to the Company
Group, “Confidential Information” also includes any and all data and information relating to or concerning a third party that otherwise meets the definition set forth above, that was provided or made available to the Company Group by such
third party, and that the Company Group has a duty or obligation to keep confidential. This definition shall not limit any definition of “confidential information” or any equivalent term under state or federal law. “Confidential
Information” shall not include information that has become generally available to the public by the act of one who has the right to disclose such information without violating any right or privilege of the Company Group. 

(iii) “Material Contact” means (i) having dealings with a customer or potential customer on behalf of the
Company Group; (ii) coordinating or supervising dealings with a customer or potential customer on behalf of the Company Group; (iii) obtaining Confidential Information about a customer or potential customer in the ordinary course of
business as a result of Employee’s employment with the Company; or (iv) receiving compensation, commissions, or earnings within the one (1) year prior to the Termination Date that resulted from the sale or provision of products or
services of the Company Group to a customer. 
 (iv) “Principal or Representative” means a principal, owner,
partner, shareholder, joint venturer, investor, member, trustee, director, officer, manager, employee, agent, representative or consultant. 

(v) “Protected Customer” means any Person to whom the Company Group has sold its products or services or
actively solicited to sell its products or services, and with whom Employee has had Material Contact on behalf of the Company Group during his employment with the Company. 

(vi) “Restrictive Covenants” means the restrictive covenants contained in Section 7 of this Agreement.

 (vii) “Restricted Period” means any time during Employee’s employment with the Company, as well as
two (2) years from Employee’s Termination Date. 
 (viii) “Termination” means the termination of
Employee’s employment with the Company, for any reason, whether with or without Cause, upon the initiative of either party. 

(ix) “Termination Date” means the date of Employee’s Termination. 

(x) “Work Product” means all ideas, formulas, recipes, discoveries, trade secrets, inventions, innovations,
improvements, developments, methods of doing business, processes, programs, designs, analyses, drawings, reports, blueprints, data, software, source code, object code, firmware, logos and all similar or related information (whether or not patentable
and whether or not reduced to practice) which relate to the Company Group’s business that are conceived, developed, acquired, contributed to, made or reduced to practice by Employee during the course of his employment with the Company (either
solely or jointly with others). 

  
 10 

 (c) Restriction on Disclosure and Use of Confidential Information. Employee agrees
that Employee shall not, directly or indirectly, use any Confidential Information on Employee’s own behalf or on behalf of any Person other than Company Group, or reveal, divulge, or disclose any Confidential Information to any Person not
expressly authorized by the Company to receive such Confidential Information. This obligation shall remain in effect for as long as the information or materials in question retain their status as Confidential Information. Employee further agrees
that he shall fully cooperate with the Company in maintaining the Confidential Information to the extent permitted by law. The parties acknowledge and agree that this Agreement is not intended to, and does not, alter either the Company’s rights
or Employee’s obligations under any state or federal statutory or common law regarding trade secrets and unfair trade practices. Anything herein to the contrary notwithstanding, Employee shall not be restricted from: (i) disclosing
information that is required to be disclosed by law, court order or other valid and appropriate legal process; provided, however, that in the event such disclosure is required by law, Employee shall provide the Company with prompt notice of such
requirement so that the Company may seek an appropriate protective order prior to any such required disclosure by Employee; (ii) reporting possible violations of federal, state, or local law or regulation to any governmental agency or entity,
or from making other disclosures that are protected under the whistleblower provisions of federal, state, or local law or regulation, and Employee shall not need the prior authorization of the Company to make any such reports or disclosures and
shall not be required to notify the Company that Employee has made such reports or disclosures; (iii) disclosing a trade secret (as defined by 18 U.S.C. § 1839) in confidence to a federal, state, or local government official, either
directly or indirectly, or to an attorney, in either event solely for the purpose of reporting or investigating a suspected violation of law; or (iv) disclosing a trade secret (as defined by 18 U.S.C. § 1839) in a complaint or other
document filed in a lawsuit or other proceeding, if such filing is made under seal. 
 (d) Work Product. Employee acknowledges that
all Work Product belongs to the Company Group. Any copyrightable work falling within the definition of Work Product shall be deemed a “work made for hire” under the copyright laws of the United States, and ownership of all rights therein
shall vest in the Company Group. To the extent that any Work Product is not deemed to be a “work made for hire,” Employee hereby assigns and agrees to assign to the Company Group all right, title and interest, including without limitation,
the intellectual property rights that Employee may have in and to such Work Product. Employee shall during the Restricted Period and thereafter promptly perform all actions reasonably requested by the Company (whether during or after the term of
this Agreement) to establish and confirm ownership of such Work Product (including, without limitation, assignments, consents, powers of attorney and other instruments) in the Company Group. 

(e) Non-Compete. Employee agrees that, during the Restricted Period, he shall not, without the
prior written consent of the Company, directly or indirectly, on his own behalf or as a Principal or Representative of any Person, engage in any Competitive Services anywhere in the United States or in any foreign country in which any member of the
Company Group has conducted business, is conducting business or is presently contemplating conducting business. 
 (f) Non-Solicitation of Protected Customers. Employee agrees that, during the Restricted Period, he shall not, without the prior written consent of the Company, directly or indirectly, on his own behalf or as a
Principal or Representative of any Person, solicit, divert, take away, or attempt to solicit, divert, or take away a Protected Customer for the purpose of engaging in, providing, or selling Competitive Services. 

(g) Non-Recruitment of Employees and Independent Contractors. Employee agrees that during the
Restricted Period, he shall not, directly or indirectly, whether on his own behalf or as a Principal or Representative of any Person, recruit, solicit, induce or hire or attempt to recruit, solicit, induce or hire any employee or independent
contractor of the Company Group to terminate his employment or other relationship with the Company Group or to enter into employment or any other kind of business relationship with the Employee or any other Person. 

  
 11 

 (h) Enforcement of Restrictive Covenants. 

(i) Rights and Remedies Upon Breach. The parties specifically acknowledge and agree that the remedy at law for any
breach of the Restrictive Covenants will be inadequate, and that in the event Employee breaches, or threatens to breach, any of the Restrictive Covenants, the Company shall have the right and remedy, without the necessity of proving actual damage or
posting any bond, to enjoin, preliminarily and permanently, Employee from violating or threatening to violate the Restrictive Covenants and to have the Restrictive Covenants specifically enforced by any court of competent jurisdiction, it being
agreed that any breach or threatened breach of the Restrictive Covenants would cause irreparable injury to the Company Group and that money damages would not provide an adequate remedy to the Company. Employee understands and agrees that if he
violates any of the obligations set forth in the Restrictive Covenants, the period of restriction applicable to each obligation violated shall cease to run during the pendency of any litigation over such violation, provided that such litigation was
initiated during the period of restriction. Such rights and remedies shall be in addition to, and not in lieu of, any other rights and remedies available to the Company at law or in equity. Employee understands and agrees that, if the Parties become
involved in legal action regarding the enforcement of the Restrictive Covenants and if the Company prevails in such legal action, the Company will be entitled, in addition to any other remedy, to recover from Employee its reasonable costs and
attorneys’ fees incurred in enforcing such covenants. The Company’s ability to enforce its rights under the Restrictive Covenants or applicable law against Employee shall not be impaired in any way by the existence of a claim or cause of
action on the part of Employee based on, or arising out of, this Agreement or any other event or transaction. 
 (ii)
Severability and Modification of Covenants. Employee acknowledges and agrees that each of the Restrictive Covenants is reasonable and valid in time and scope and in all other respects. The parties agree that it is their intention that the
Restrictive Covenants be enforced in accordance with their terms to the maximum extent permitted by law. Each of the Restrictive Covenants shall be considered and construed as a separate and independent covenant. Should any part or provision of any
of the Restrictive Covenants be held invalid, void, or unenforceable, such invalidity, voidness, or unenforceability shall not render invalid, void, or unenforceable any other part or provision of this Agreement or such Restrictive Covenant. If any
of the provisions of the Restrictive Covenants should ever be held by a court of competent jurisdiction to exceed the scope permitted by the applicable law, such provision or provisions shall be automatically modified to such lesser scope as such
court may deem just and proper for the reasonable protection of the Company’s legitimate business interests and may be enforced by the Company to that extent in the manner described above and all other provisions of this Agreement shall be
valid and enforceable. 
 8. Cooperation. During and after Employee’s Employment, Employee shall cooperate fully with the Company
in the defense or prosecution of any claims or actions now in existence or which may be brought in the future against or on behalf of the Company that relate to events or occurrences that transpired while Employee was employed by the Company.
Employee’s full cooperation in connection with such claims or actions shall include, but not be limited to, being available to meet with counsel to prepare for discovery or trial and to act as a witness on behalf of the Company at mutually
convenient times. During and after the Employment, Employee also shall cooperate fully with the Company in connection with any investigation or review of any federal, state or local regulatory authority as any such investigation or review relates to
events or occurrences that transpired while Employee was employed by the Company. Subject to Section 17(d), the Company shall reimburse Employee for any reasonable fees and reasonable out-of-pocket expenses incurred in connection with Employee’s performance of obligations pursuant to this Section 8 and such cooperation shall be at reasonable times and upon reasonable advance
notice. 

  
 12 

 Employee agrees, while he is employed by the Company, to offer or otherwise make known or available to it,
as directed by the Board of the Company and without additional compensation or consideration, any business prospects, contracts or other business opportunities that Employee may discover, find, develop or otherwise have available to Employee in the
Company’s general industry and further agrees that any such prospects, contacts or other business opportunities shall be the property of the Company Group. 

9. Governing Law; Waiver of Jury Trial. This Agreement shall be governed by and construed under the laws of the State of North Carolina,
without consideration of its choice of law provisions, and shall not be amended, modified or discharged in whole or in part except by an agreement in writing signed by both of the parties hereto. EACH OF THE PARTIES HERETO HEREBY IRREVOCABLY WAIVES
ANY AND ALL RIGHT TO TRIAL BY JURY IN ANY LEGAL PROCEEDING ARISING OUT OF OR RELATED TO THIS AGREEMENT. Each of the parties hereto expressly submits and consents in advance to the sole and exclusive jurisdiction of the state and federal courts
located in the State of North Carolina for the purposes of any and all suits, actions or other proceedings or other disputes arising out of, based on or relating to this Agreement. Each of the parties hereto hereby waives, and agrees not to assert,
by way of motion, as a defense, or otherwise, in any such suit, action or proceeding brought in such courts, any claim that it is not subject personally to the jurisdiction of the above-named courts, that its property is exempt or immune from
attachment or execution, that the suit, action or proceeding is brought in an inconvenient forum, that the venue of the suit, action or proceeding is improper or that this Agreement or the subject matter hereof may not be enforced in or by such
court, in each case, unless another jurisdiction is required to enforce the rights of Parent and/or the Company under this Agreement. The parties hereto hereby consent to service of process by mail and any other manner permitted by law or this
Agreement. The parties acknowledge that all directions issued by the forum court, including all injunctions and other decrees, may be filed, and will be binding and enforceable, in all jurisdictions. Except as otherwise provided in Section 7,
if any legal action or other proceeding is brought for the enforcement of this Agreement, or because of an alleged dispute, breach, default or misrepresentation in connection with any provisions of this Agreement, the successful or prevailing party
or parties shall be entitled to recover reasonable attorney’s fees, court costs and reasonable expenses incurred in that action or proceeding, in addition to any other relief to which such party or parties may be entitled. 

10. Notices. All notices, requests, demands and other communications hereunder shall be in writing and shall be deemed to have been duly
given if delivered personally or mailed by certified or registered mail (return receipt requested) as follows: 
  

			
	To the Company:	 	CommScope, Inc.
		 	1100 CommScope Place, SE
		 	Hickory, NC 28602
		 	Attention: General Counsel
		
	With copy to:	 	Alston & Bird LLP
		 	101 South Tryon Street
		 	Suite 4000
		 	Charlotte, North Carolina 28280
		 	Attention: C. Mark Kelly, Esq. 
		
	To Employee:	 	Charles L. Treadway
		 	1 Robledo Drive
		 	Dallas, Texas 75230

  
 13 

 or to such other address of which any party may notify the other parties as provided above. Notices shall be
effective as of the date of such delivery or mailing. 
 11. Indemnification. During the Employment, Employee shall be entitled to
such rights regarding indemnification and advancement of expenses as are provided in the Indemnification Agreement, dated as of the Effective Date, by and between Employee and the Company, and as provided under the Company’s Certificate of
Incorporation or By-laws, as they made be amended from time to time. 
 12. Scope of
Agreement. The parties acknowledge that the time, scope, geographic area and other provisions of Section 7 have been specifically negotiated by sophisticated parties and agree that all such provisions are reasonable under the circumstances
of the transactions contemplated hereby and are given as an integral and essential part of the Employment contemplated hereby. Employee has independently consulted with counsel and has been advised in all respects concerning the reasonableness and
propriety of the covenants contained herein, with specific regard to the business to be conducted by the Company Group, and represents that the Agreement is intended to be, and shall be, fully enforceable and effective in accordance with its terms.

 13. Severability. The existence of any claim or cause of action which Employee may have against the Company or Parent shall not
constitute a defense or bar to the enforcement of any of the provisions of this Agreement. The invalidity, illegality or unenforceability of any provision of this Agreement shall in no way affect the validity, legality or enforceability of any other
provision. 
 14. Counterparts Facsimile Signatures. This Agreement may be executed in one or more counterparts, all of which taken
together shall constitute one and the same Agreement. Each party may rely upon the execution of this Agreement by the other party via the facsimile signature as if such facsimile signature were an original signature. 

15. Miscellaneous. This Agreement shall not be amended, modified or discharged in whole or in part except by an agreement in writing
signed by both of the parties hereto. The failure of either of the parties to require the performance of a term or obligation or to exercise any right under this Agreement or the waiver of any breach hereunder shall not prevent subsequent
enforcement of such term or obligation or exercise of such right or the enforcement at any time of any other right hereunder or be deemed a waiver of any subsequent breach of the provision so breached, or of any other breach hereunder. This
Agreement shall inure to the benefit of and be binding upon and assignable to, successors of the Company by way of merger, consolidation or sale and may not be assigned by Employee. This Agreement supersedes and terminates all prior understandings
and agreements between the parties (or their predecessors) relating to the subject matter hereof; provided, however, this agreement shall not alter or limit the obligations of Employee pursuant to any other confidentiality, noncompetition,
nonsolicitation or similar agreement applicable to Employee. 
 16. Certain Definitions. For purposes of this Agreement, except as
otherwise provided herein, the term “subsidiary” of a Person means any corporation more than 50% of whose outstanding voting securities, or any partnership, joint venture or other entity more than 50% of whose total equity
interests, is directly or indirectly owned by such Person. 

  
 14 

 17. Internal Revenue Code Section 409A. 

(a) It is the intent of the parties that this Agreement shall be interpreted and administered in a manner so that any amount or benefit payable
hereunder shall be paid or provided in a manner that is either exempt from or compliant with the requirements Section 409A of the Internal Revenue Code of 1986, as amended (the “Code”), and applicable Internal Revenue Service
guidance and Treasury Regulations issued thereunder (and any applicable transition relief under Section 409A of the Code). Neither the Company Group, nor their directors, officers, employees or advisers shall be held liable for any taxes,
interest, penalties or other monetary amounts owed by Employee as a result of the application of Section 409A of the Code. 
 (b)
Notwithstanding anything in this Agreement to the contrary, to the extent that the severance payments under Section 6(e) and any other amount or benefit under this Agreement, constitutes non-exempt
“deferred compensation” for purposes of Section 409A of the Code (“Non-Exempt Deferred Compensation”) and that would otherwise be payable or distributable hereunder by reason of
Employee’s termination of Employment, such amounts will not be payable or distributable to Employee unless the circumstances giving rise to such termination of Employment meet any description or definition of “separation from service”
in Section 409A of the Code and applicable regulations (without giving effect to any elective provisions that may be available under such definition). This provision does not prohibit the vesting of any amount upon Employee’s termination
of Employment or the determination of the amounts owed to him due to such termination. If this provision prevents the payment or distribution of any amount or benefit, such payment or distribution shall be made on the date, if any, on which an event
occurs that constitutes a Section 409A-compliant “separation from service.” 
 (c) Whenever in this Agreement the provision of
payment or benefit is conditioned on Employee’s execution and non-revocation of the Release, provided that the Release has been timely delivered to Employee not later than ten (10) days after
the date of termination of Employment, such Release must be executed, and all applicable revocation periods shall have expired, within sixty (60) days after the date of termination of Employee’s Employment, failing which such payment or
benefit shall be forfeited. If such payment or benefit constitutes Non-Exempt Deferred Compensation, and if such 60-day period begins in one calendar year and ends in
the next calendar year, the payment or benefit shall not be made or commence before the second such calendar year, even if the Release becomes irrevocable in the first such calendar year. In other words, Employee is not permitted to influence the
calendar year of payment based on the timing of his signing of the Release. 
 (d) If Employee is entitled to be paid or reimbursed for any
taxable expenses under this Agreement, and such payments or reimbursements are includible in Employee’s federal gross taxable income, the amount of such expenses reimbursable in any one calendar year shall not affect the amount reimbursable in
any other calendar year, and the reimbursement of an eligible expense must be made no later than December 31 of the year after the year in which the expense was incurred. No right of Employee to reimbursement of expenses under this Agreement
shall be subject to liquidation or exchange for another benefit. 
 (e) Each payment of termination benefits under Section 6 of this
Agreement, including, without limitation, each payment of COBRA Cost under Section 6(e)(iv), shall be considered a separate payment, as described in Treas. Reg. Section 1.409A-2(b)(2), for purposes
of Section 409A of the Code. 

  
 15 

 (f) Notwithstanding anything in this Agreement to the contrary, if any amount or benefit
that would constitute Non-Exempt Deferred Compensation would otherwise be payable or distributable under this Agreement by reason of Employee’s separation from service during a period in which he is a
Specified Employee (as defined below), then, subject to any permissible acceleration of payment by the Company under Treas. Reg. Section 1.409A-3(j)(4)(ii) (domestic relations order), (j)(4)(iii)
(conflicts of interest), or (j)(4)(vi) (payment of employment taxes): (i) the amount of such Non-Exempt Deferred Compensation that would otherwise be payable during the
six-month period immediately following Employee’s separation from service will be accumulated through and paid or provided on the first day of the seventh month following Employee’s separation from
service (or, if Employee dies during such period, within 30 days after his death) (in either case, the “Required Delay Period”); and (ii) the normal payment or distribution schedule for any remaining payments or distributions
will resume at the end of the Required Delay Period. For purposes of this Agreement, the term “Specified Employee” has the meaning given such term in Code Section 409A and the final regulations thereunder. 

18. Limitation of Benefits. 

(a) Anything in this Agreement to the contrary notwithstanding, in the event it shall be determined that any benefit, payment or distribution
by the Company, Parent or any of their direct and/or indirect subsidiaries to or for the benefit of Employee (whether paid or payable or distributed or distributable pursuant to the terms of this Agreement or otherwise, but determined without regard
to any additional payments required under this Section 18) (such benefits, payments or distributions are hereinafter referred to as “Payments”) would, if paid, be subject to the excise tax imposed by Section 4999 of the
Code (the “Excise Tax”), then, prior to the making of any Payments to Employee, a calculation shall be made comparing (i) the net after-tax benefit to Employee of the Payments after
payment by Employee of the Excise Tax, to (ii) the net after-tax benefit to Employee if the Payments had been limited to the extent necessary to avoid being subject to the Excise Tax. If the amount
calculated under (i) above is less than the amount calculated under (ii) above, then the Payments shall be limited to the extent necessary to avoid being subject to the Excise Tax (the “Reduced Amount”). The reduction of
the Payments due hereunder, if applicable, shall be made by first reducing cash Payments and then, to the extent necessary, reducing those Payments having the next highest ratio of Parachute Value to actual present value of such Payments as of the
date of the change of control, as determined by the Determination Firm (as defined in Section 18(b) below). For purposes of this Section 18, present value shall be determined in accordance with Section 280G(d)(4) of the Code. For
purposes of this Section 18, the “Parachute Value” of a Payment means the present value as of the date of the change of control of the portion of such Payment that constitutes a “parachute payment” under
Section 280G(b)(2) of the Code, as determined by the Determination Firm for purposes of determining whether and to what extent the Excise Tax will apply to such Payment. 

(b) All determinations required to be made under this Section 18, including whether an Excise Tax would otherwise be imposed, whether the
Payments shall be reduced, the amount of the Reduced Amount, and the assumptions to be used in arriving at such determinations, shall be made by an independent, nationally recognized accounting firm or compensation consulting firm mutually
acceptable to the Company and Employee (the “Determination Firm”) which shall provide detailed supporting calculations both to the Company and Employee. All fees and expenses of the Determination Firm shall be borne solely by the
Company. Any determination by the Determination Firm shall be binding upon the Company and Employee. As a result of the uncertainty in the application of Section 4999 of the Code at the time of the initial determination by the Determination
Firm hereunder, it is possible that Payments hereunder will have been unnecessarily limited by this Section 18 (“Underpayment”), consistent with the calculations required to be made hereunder. The Determination Firm shall
determine the amount of the Underpayment that has occurred and any such Underpayment shall be promptly paid by the Company to or for the benefit of Employee, but no later than March 15 of the year after the year in which the Underpayment is
determined to exist, which is when the legally binding right to such Underpayment arises. 

  
 16 

 19. Non-exclusivity of Rights. Nothing in
this Agreement shall prevent or limit Employee’s continuing or future participation in any employee benefit plan, program, policy or practice provided by the Company and for which Employee may qualify, except as specifically provided herein.
Amounts that are vested benefits or which Employee is otherwise entitled to receive under any plan, policy, practice or program of the Company at or subsequent to the date of termination of Employment shall be payable in accordance with such plan,
policy, practice or program except as explicitly modified by this Agreement. For the avoidance of doubt, no provision of this Agreement is meant to modify or limit Employee’s right to receive his vested supplemental executive retirement plan
benefits, if any, and to exercise his vested options, if any, in accordance with the terms of the applicable plan documents, related agreements and operative prior elections. 

20. Full Settlement; No Mitigation. The Company’s obligation to make the payments provided for in this Agreement and otherwise to
perform its obligations hereunder shall not be affected by any set-off, counterclaim, recoupment, defense or other claim, right or action which the Company may have against Employee or others. In no event
shall Employee be obligated to seek other employment or take any other action by way of mitigation of the amounts payable to Employee under any of the provisions of this Agreement and such amounts shall not be reduced whether or not Employee obtains
other employment. 
 [REMAINDER OF PAGE INTENTIONALLY LEFT
BLANK] 

  
 17 

 IN WITNESS WHEREOF, the parties have executed this Agreement under seal as of the date first
set forth above. 
  

			
	COMPANY
	
	COMMSCOPE, INC.
		
	By:	 	  /s/ Frank B. Wyatt, II

		 	Name: Frank B. Wyatt, II
		 	Title:   Senior Vice President
	
	EMPLOYEE
	
	  /s/ Charles L. Treadway

	Charles L. Treadway

  
 18

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00314-of-00352.parquet"}]]